Pathogenesis and treatment of acne at women’s hyperandrogenism syndrome

Cite item


Аспе is one of most spread people’s disease and is characterized by the piloseboceial complex affection. Acne pathogenesis is a multifactor one, and the hyperandrogenism favors the disease development. The article highlights the acne pathogenesis, discusses methods of the endocrinologic examination and treatment of women’s hyperandrogenism.

Full Text

Патогенез и лечение акне при синдроме гиперандрогении у женщин

About the authors




  1. Downing D. T., Strauss J. S., Pochi P. E. Variability in the chemical composition of human skin surface lipids. J Invest Dermatol 1969; 53: 322-7.
  2. Leyden J.J. New understandigs of the pathogenesis of acne. J Am Acad Dermatol 1995; 32: 15-25.
  3. Thomas D. R. Psychosocial effects of acne. J Cutan Med Surg 2004; 8: (4): 3-5.
  4. Zouboulis C.C., Eady A., Philpott M., et al. What is the pathogenesis of acne? Exp Dermatol 2005; 14: (2): 143-52.
  5. Makrantonaki E., Ganceviciene R., Zouboulis C. An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinol 2011; 3: (1): 41-9.
  6. Ebede T.L., Arch E.L., Berson D. Hormonal treatment of acne in women. J Clin Aesthet Dermatol 2009; 2: (12): 16-22.
  7. Sansone G., Reisner R. M. Differential rates of conversion of testosterone to dihydrotestosterone in acne and in normal human skin--a possible pathogenic factor in acne. J Invest Dermatol 1971; 56: (5): 366-72.
  8. Giltay E. J., Gooren L. J. Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females. J Clin Endocrinol Metab 2000; 85: (8): 2913-21.
  9. Pochi P. E., Strauss J. S. Sebaceous gland response in man to the administration of testosterone, delta-4-androstenedione, and dehydroisoandrosterone. J Invest Dermatol 1969; 52: (1): 32-6.
  10. Akamatsu H., Zouboulis C. C., Orfanos C. E. Control of human sebocyte proliferation in vitro by testosterone and 5-alpha-dihydrotestosterone is dependent on the localization of the sebaceous glands. J Invest Dermatol 1992; 99: (4): 509-11.
  11. Zouboulis C. C., Seltmann H., Neitzel H. et al. Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol 1999; 113: (6):1011-20.
  12. Chen W., Yang C. C., Sheu H. M. et al. Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol 2003; 121: (3): 441-7.
  13. Rosenfield R. L., Deplewski D., Kentsis A. et al. Mechanisms of androgen induction of sebocyte differentiation. Dermatology 1998; 196(1): 43-6.
  14. Makrantonaki E., Zouboulis C. C. Testosterone metabolism to 5alpha-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferator-activated receptor ligand linoleic acid in human sebocytes. Br J Dermatol 2007; 156: (3): 428-32.
  15. Strauss J. S., Krowchuk D. P., Leyden J.J. et al. American Academy of Dermatology/American Academy of Dermatology Association. Guidelines of care for acne vulgaris management. J Am Acad Dermatol 2007; 56: (4): 651-63.
  16. Vermeulen A., Verdonck L., Kaufman J. M. A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum J Clin Endocrinol Metab 1999; 84: 3666-3672.
  17. Arowojolu A. O., Gallo M. F., Lopez L. M. et al. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev 2009; (3): CD004425.
  18. Palep-Singh M., Mook K., Barth J. et al. An observational study of Yasmin in the management of women with polycystic ovary syndrome. J Fam Plann Reprod Health Care 2004; 30: (3): 163-5.
  19. Carmina E., Lobo R.A. A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women. Clin Endocrinol (Oxf) 2002; 57: (2): 231-4.
  20. Brown J., Farquhar C., Lee O. et al. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database Syst Rev 2009; (2): CD000194.
  21. Волкова Е. Н., Есимбиева М. Л., Ландышева К. А. et al. Инновация ведения больных с акне: предварительные результаты лечения. Клин дерматол и венерол 2011; (1): 59-63.
  22. Goodfield M. J., Cox N. H., Bowser A. et al. Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010. Br J Dermatol 2010; 162: 1172-9.
  23. Nast A., Dreno B., Bettoli Vet al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol 2012; 26: (1): 1-29.

Copyright (c) 2012 GRODNITSKAYA E.E., KURTSER M.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 60448 от 30.12.2014.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies